# POMBILITI ATGA

NDC: 71904-200
Generic name: cipaglucosidase alfa-atga
Labeler / Manufacturer: AMICUS THERAPEUTICS US, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20231011

FDA application: BLA761204

## Active ingredients

- CIPAGLUCOSIDASE ALFA: 105 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71904-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71904-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d77aa596-910d-516b-e053-2995a90a0839